These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
408 related articles for article (PubMed ID: 8819215)
1. Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day. Orskov C; Wettergren A; Holst JJ Scand J Gastroenterol; 1996 Jul; 31(7):665-70. PubMed ID: 8819215 [TBL] [Abstract][Full Text] [Related]
2. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
3. What do we know about the secretion and degradation of incretin hormones? Deacon CF Regul Pept; 2005 Jun; 128(2):117-24. PubMed ID: 15780431 [TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1? Holst JJ BioDrugs; 2002; 16(3):175-81. PubMed ID: 12102645 [TBL] [Abstract][Full Text] [Related]
5. Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight. Schou JH; Pilgaard K; Vilsbøll T; Jensen CB; Deacon CF; Holst JJ; Vølund A; Madsbad S; Vaag AA J Clin Endocrinol Metab; 2005 Aug; 90(8):4912-9. PubMed ID: 15899957 [TBL] [Abstract][Full Text] [Related]
6. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations. Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405 [TBL] [Abstract][Full Text] [Related]
7. Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. Holst JJ; Gromada J Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E199-206. PubMed ID: 15271645 [TBL] [Abstract][Full Text] [Related]
8. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans. Christensen MB Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187 [TBL] [Abstract][Full Text] [Related]
9. Gastric emptying and release of incretin hormones after glucose ingestion in humans. Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855 [TBL] [Abstract][Full Text] [Related]
10. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666 [TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. Elliott RM; Morgan LM; Tredger JA; Deacon S; Wright J; Marks V J Endocrinol; 1993 Jul; 138(1):159-66. PubMed ID: 7852887 [TBL] [Abstract][Full Text] [Related]
12. Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males. Zilstorff DB; Richter MM; Hannibal J; Jørgensen HL; Sennels HP; Wewer Albrechtsen NJ BMC Endocr Disord; 2024 Mar; 24(1):38. PubMed ID: 38481208 [TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 and control of insulin secretion. Thorens B Diabete Metab; 1995 Dec; 21(5):311-8. PubMed ID: 8586147 [TBL] [Abstract][Full Text] [Related]
14. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction. Verdich C; Toubro S; Buemann B; Lysgård Madsen J; Juul Holst J; Astrup A Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1206-14. PubMed ID: 11477506 [TBL] [Abstract][Full Text] [Related]
15. Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Fukase N; Igarashi M; Takahashi H; Manaka H; Yamatani K; Daimon M; Tominaga M; Sasaki H Diabet Med; 1993; 10(1):44-9. PubMed ID: 8435987 [TBL] [Abstract][Full Text] [Related]
16. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects. Meier JJ; Nauck MA; Kranz D; Holst JJ; Deacon CF; Gaeckler D; Schmidt WE; Gallwitz B Diabetes; 2004 Mar; 53(3):654-62. PubMed ID: 14988249 [TBL] [Abstract][Full Text] [Related]
17. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections. Nauck MA; Siemsglüss J; Orskov C; Holst JJ Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968 [TBL] [Abstract][Full Text] [Related]
18. Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males. Wu T; Rayner CK; Watson LE; Jones KL; Horowitz M; Little TJ Peptides; 2017 Sep; 95():124-127. PubMed ID: 28800948 [TBL] [Abstract][Full Text] [Related]
19. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion. Jia X; Brown JC; Ma P; Pederson RA; McIntosh CH Am J Physiol; 1995 Apr; 268(4 Pt 1):E645-51. PubMed ID: 7733263 [TBL] [Abstract][Full Text] [Related]
20. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8. Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]